Homocysteine, MTHFR C677 T, vitamin B12, and folate levels in Thai children with ischemic stroke: A case-control study

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 12, 2006, Pages 803-808

  Sirachainan, Nongnuch ^a   Tapanapruksakul, Pornsri ^a   Visudtibhan, Anannit ^a   Chuansumrit, Ampaiwan ^a   Cheeramakara, Cheeraratana ^a   Atamasirikul, Kalayanee ^a   Chotsuppakarn, Sukanya ^a   Areekul, Suvit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Children; Folate; Homocysteine; Ischemic stroke; MTHFR; Thai; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; HEREDITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; SCHOOL CHILD; THAILAND; VITAMIN BLOOD LEVEL;

ADOLESCENT; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INFANT; ISCHEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS; THAILAND; THROMBOSIS; VITAMIN B 12;

EID: 33845718808     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31802d3e8a     Document Type: Article

References (48)

1. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83:1251-1257.
2. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28:763-768.
3. Broderick J, Talbot GT, Prenger E, et al. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
4. Fullerton HJ, Wu YW, Zhao S, et al. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189-194.
5. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004;114:e206-e212.
6. Chumnijarakij T. Incidence of postpartum thromboembolism in Thai women: comparison with Western experience. J Med Assoc Thai. 1974;57:592-594.
7. Chumnijarakij T, Poshyachinda V. Postoperative thrombosis in Thai women. Lancet. 1975;1:1357-1358.
8. Atichartakarn V, Pathepchotiwong K, Keorochana S, et al. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med. 1988;148:1349-1353.
9. Angchaisuksiri P, Pingsuthiwong S, Sura T, et al. Prevalence of the C677T methylenetetra-hydrofolate reductase mutation in Thai patients with deep vein thrombosis. Acta Haematol. 2000;103:191-196.
10. Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, et al. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol. 2000;65:119-122.
11. Chuansumrit A, Jarutwachirakul W, Sasanakul W, et al. Prevalence of factor V Leiden in Thai blood donors. J Med Assoc Thai. 2001;84:489-493.
12. Nasiruddin N, Zahur ur R, Anwar M, et al. Frequency of factor V leiden mutation. J Coll Physicians Surg Pak. 2005;15:15-17.
13. Gupta N, Khan F, Tripathi M, et al. Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India. Indian J Med Sci. 2003;57:535-542.
14. Chen TY, Su WC, Tsao CJ. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Ann Hematol. 2003;82:114-117.
15. Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002;106:7-12.
16. Yusoff NM, Abdullah WZ, Ghazali S, et al. The absence of factor V Leiden mutation in Malays with recurrent spontaneous abortions. Aust N Z J Obstet Gynaecol. 2002;42:164-166.
17. Visudhiphan S, Poolsuppasit S, Piboonnukarintr O, et al. The relationship between high fibrinolytic activity and daily capsicum ingestion in Thais. Am J Clin Nutr. 1982;35:1452-1458.
18. Klatsky AL, Baer D. What protects Asians from venous thromboembolism? Am J Med. 2004;116:493-495.
19. Moller J, Nielsen GM, Tvedegaard KC, et al. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest. 2000;60:491-499.
20. Lee R, Frenkel EP. Hyperhomocysteinemia and thrombosis. Hematol Oncol Clin North Am. 2003;17:85-102.
21. Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998;158:2101-2106.
22. Li Z, Sun L, Zhang H, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke. 2003;34:2085-2090.
23. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1-11.
24. Kosch AK, Heinecke HG, Kurnik A, et al. Childhood Thrombophilia Study Group. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost. 2004;91:308-314.
25. Carson NA, Neill DW.Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child. 1962;37:505-513.
26. Pezzini A, DelZotto E, Archetti S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664-669.
27. Delvin EE, Rozen R, Merouani A, et al. Influence of methylenetetrahydrofolate reductase genotype, age, vitamin B-12, and folate status on plasma homocysteine in children. Am J Clin Nutr. 2000;72:1469-1473.
28. Todesco L, Angst C, Litynski P, et al. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest. 1999;29:1003-1009.
29. Jacques PF, Bostom AG, Wilson PW, et al. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613-621.
30. Lussier-Cacan S, Xhignesse M, Piolot A, et al. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr. 1996;64:587-593.
31. Morris MS, Jacques PF, Selhub J, et al. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2000;152:140-148.
32. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;3:1646-1654.
33. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015-2022.
34. van Beynum IM, Smeitink JA, den Heijer M, et al. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation. 1999;99:2070-2072.
35. Grossowicz N, Mandelbaum-Shavit F, Davidoff R, et al. Microbiologic determination of folic acid derivatives in blood. Blood. 1962;20:609-616.
36. Areekul S, Devakul K, Boonyananta C, et al. Studies on vitamin B 12 and folic acid absorption in patients with opisthorchis infection. J Med Assoc Thai. 1971;54:483-488.
37. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
38. Chan AK, Deveber G, Monagle P, et al. Venous thrombosis in children. J Thromb Haemost. 2003;1:1443-1455.
39. Barnes C, Deveber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res. 2006;118:67-74.
40. Brattstrom L, Wilcken DE, Ohrvik J, et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98:2520-2526.
41. Stabler SP, Marcell PD, Podell ER, et al. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest. 1988;81:466-474.
42. Chu RC, Hall CA. The total serum homocysteine as an indicator of vitamin B12 and folate status. Am J Clin Pathol. 1988;90:446-449.
43. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458-462.
44. Gao X, Yao M, McCrory MA, et al. Dietary pattern is associated with homocysteine and B vitamin status in an urban Chinese population. J Nutr. 2003;133:3636-3642.
45. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 1998;316:894-898.
46. McKinley MC, McNulty H, McPartlin J, et al. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr. 2001;73:759-764.
47. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
48. Boysen G, Brander T, Christensen H, et al. Homocysteine and risk of recurrent stroke. Stroke. 2003;34:1258-1261.